<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03646045</url>
  </required_header>
  <id_info>
    <org_study_id>741563-9</org_study_id>
    <nct_id>NCT03646045</nct_id>
  </id_info>
  <brief_title>Transpyloric Feeding for Prevention of Micro-aspiration</brief_title>
  <official_title>Transpyloric Feeding for Prevention of Micro-aspiration</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nemours Children's Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nemours Biomedical Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nemours Children's Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the effect of transpyloric (TP) feeding on microaspiration and lung inflammation
      in ventilated preterm infants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Specific Aim 1): To determine the effect of TP feeding on microaspiration and lung
      inflammation. Hypothesis: TP feeding will reduce the microaspiration and pulmonary
      inflammation in ventilated preterm infants. Evaluate markers of microaspiration (pepsin A)
      and lung inflammation [total cell counts, nuclear factor-kB (NF-kB) activation, tumor
      necrosis factor-α (TNF-α), IL-1β, IL-6, IL-8, angiopoietin 2 (Ang2), high-mobility group
      box-1 protein (HMGB1), macrophage migration inhibitory factor (MIF) and interferon-γ (IFN-γ)]
      in TA samples obtained from preterm ventilated infants with and without TP feeding.

      Specific Aim 2): To determine the effect of TP feeding on respiratory support. Hypothesis: TP
      feeding will decrease the respiratory severity score (RSS) [Fraction of inspired oxygen
      (FiO2) X mean airway pressure (MAP)] and number of infants requiring ventilator support.
      Evaluate respiratory support in preterm ventilated infants with and without TP feeding.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">November 4, 2016</start_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Tracheal aspirate pepsin A levels in ventilated preterm infants receiving transpyloric feeding and gastric feeding.</measure>
    <time_frame>3-7 days</time_frame>
    <description>Difference in tracheal aspirate pepsin A levels in preterm ventilated infants receiving transpyloric feeding and gastric feeding.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tracheal aspirate pepsin A levels in ventilated preterm infants before and after transpyloric feeding.</measure>
    <time_frame>3-7 days</time_frame>
    <description>Change in tracheal aspirate pepsin A levels in preterm ventilated infants before and after transpyloric feeding.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tracheal aspirate cytokines levels (TNF-α, IL-1β, IL-6, IL-8, Ang2, HMGB1, MIF and IFN-gamma) in ventilated preterm infants receiving transpyloric feeding and gastric feeding.</measure>
    <time_frame>3-7 days.</time_frame>
    <description>Difference in tracheal aspirate cytokines levels (TNF-α, IL-1β, IL-6, IL-8, Ang2, HMGB1, MIF and IFN-gamma) in preterm ventilated infants receiving transpyloric feeding and gastric feeding.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tracheal aspirate cytokines levels (TNF-α, IL-1β, IL-6, IL-8, Ang2, HMGB1, MIF and IFN-gamma) in ventilated preterm infants before and after transpyloric feeding.</measure>
    <time_frame>3-7 days</time_frame>
    <description>Change in tracheal aspirate cytokines levels (TNF-α, IL-1β, IL-6, IL-8, Ang2, HMGB1, MIF and IFN-gamma) in preterm ventilated infants before and after transpyloric feeding.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory support in ventilated preterm infants receiving transpyloric feeding and gastric feeding.</measure>
    <time_frame>7-14 days</time_frame>
    <description>Difference in respiratory severity score (FiO2 X mean airway pressure) in preterm ventilated infants receiving transpyloric feeding and gastric feeding.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory support in ventilated preterm infants before and transpyloric feeding.</measure>
    <time_frame>7-14 days</time_frame>
    <description>Change in respiratory severity score (FiO2 X mean airway pressure) in preterm ventilated infants before and after transpyloric feeding.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">46</enrollment>
  <condition>Microaspiration</condition>
  <condition>Gastro Esophageal Reflux</condition>
  <arm_group>
    <arm_group_label>Transpyloric feed</arm_group_label>
    <description>Preterm infant receiving transpyloric feeding.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Preterm infants receiving gastric feeding</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Transpyloric feeding</intervention_name>
    <description>Preterm infant feeding using transpyloric feeding tube (nasoduodenal tube)</description>
    <arm_group_label>Transpyloric feed</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Tracheal aspirate samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Preterm infants (birth weight &lt;1500 grams) requiring ventilator support.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Preterm infants with birth weight &lt;1500 grams

          -  Requiring ventilatory support

        Exclusion Criteria:

          -  Culture-proven sepsis

          -  Ventilator associated pneumonia (VAP).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>12 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zubair H Aghai, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nemours</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zubair Aghai, MD</last_name>
    <email>zubair.aghai@nemours.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>AI duPont Hospital for Children</name>
      <address>
        <city>Wilmington</city>
        <state>Delaware</state>
        <zip>19803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zubair Aghai, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zubair Aghai, MD</last_name>
      <email>zaghai@nemours.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>July 30, 2018</study_first_submitted>
  <study_first_submitted_qc>August 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 24, 2018</study_first_posted>
  <last_update_submitted>August 22, 2018</last_update_submitted>
  <last_update_submitted_qc>August 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

